Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 09-05-2025: Board Meeting

Venmax Drugs & Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year. Revenue from operations rose to Rs. 33.28 lakh in the latest quarter from Rs. 19.92 lakh previously, while total revenue surged to Rs. 186.05 lakh for the year. The company posted a profit before tax of Rs. 77.49 lakh for the quarter but reported a slight loss of Rs. 1.41 lakh for the year. Earnings per share were Rs. 1.485 for the quarter and slightly negative for the year. The company raised funds through allotment of 1.00 crore convertible equity share warrants to non-promoters, with ₹50.7 Cr received as application money, boosting cash and cash equivalents to Rs. 248.24 lakh. No borrowings remain long-term; current liabilities increased modestly. The audit report was unqualified, confirming clean financials. This reflects efforts to strengthen liquidity while managing operating losses over the year.